share_log

Healixa Appoints Diane Koontz As President of Healixa Health Care

Healixa Appoints Diane Koontz As President of Healixa Health Care

Healixa任命黛安·孔茨為Healixa Healthcare的總裁
GlobeNewswire ·  2022/10/26 21:10

Healixa, Inc. (OTC: EMOR) Bolsters Its Executive Team with Appointment of Accomplished Health Care Executive

Healixa,Inc.(場外交易代碼:EMOR)任命富有成就的醫療保健高管以增強其高管團隊

Manhattan, NY, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa", or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, today announces that Diane Koontz has been appointed President of Healixa Health Care, effective immediately, demonstrating the Company's commitment to its PurelyRx® digital ecosystem.

紐約曼哈頓,2022年10月26日(環球通訊社)--Healixa,Inc.(場外交易代碼:EMOR)(以下簡稱“Healixa”或“公司”)今天宣佈,Diane Koontz已被任命為Healixa Health Care的總裁,即刻生效,這表明了該公司對其PurelyRx®數字生態系統的承諾。

Diane Koontz is an accomplished health care executive. Ms. Koontz previously served as President of Managed Health Care Associates, Inc. ("MHA"), one of the largest group purchasing organization ("GPO") in the United States, and a leading health care services and software company focused on the needs of alternate site health care providers.  

黛安·孔茨是一位頗有成就的醫療保健高管。Koontz女士之前曾在美國最大的團購組織之一管理式醫療保健協會公司(“MHA”)擔任總裁,也是一家專注於替代地點醫療保健提供者需求的領先醫療保健服務和軟件公司。

During her 24+ year career at MHA, Ms. Koontz has been involved in almost every facet of the GPO business, with extensive experience in finance, sales, operations, reimbursement management, pharmacy network management, software development, and contract negotiations within the industry representing the alternate site health care provider markets. Under her leadership, MHA built a leading network of solutions to the alternate site healthcare market and powerful technology tools and proven customer-service model continue to drive growth in their multiple niches. 

在她24年多的MHA職業生涯中,Koontz女士幾乎參與了GPO業務的方方面面,在財務、銷售、運營、報銷管理、藥房網絡管理、軟件開發和代表替代地點醫療保健提供商市場的行業內的合同談判方面擁有豐富的經驗。在她的領導下,MHA建立了領先的替代地點醫療保健市場解決方案網絡,強大的技術工具和成熟的客户服務模式繼續推動其多個利基市場的增長。

"The appointment of Diane Koontz as President of Healixa Health Care should signal to the industry that our PurelyRx® digital ecosystem is now fortified by a very experience and accomplished health care executive," commented Ian Parker, Chief Executive Officer of Healixa. "In her previous position, Diane was an interictal part of creating attractive cash return characteristics and generating substantial recurring revenue through long-term customer relationships and very high retention rates."

Healixa首席執行官伊恩·帕克評論説:“任命黛安·孔茨為Healixa Healxa Healthcare的總裁應該向業界表明,我們的PurelyRx®數字生態系統現在得到了非常豐富的經驗和出色的醫療管理人員的加強。”在她之前的職位上,黛安是創造有吸引力的現金回報特徵並通過長期客户關係和非常高的保留率創造可觀的經常性收入的中間部分。

Ms. Koontz added, "I am excited to join and lead Healixa's Health Care division as we launch innovative technology solutions to enhance the providers, pharmacies and patients' experiences.   I am confident that we will be in a position to advance healthcare to be more patient centric and value based with our offerings." 

Koontz女士補充説:“我很高興能加入並領導Healixa的醫療保健部門,因為我們推出了創新的技術解決方案,以提升供應商、藥店和患者的體驗。我相信,我們將能夠通過我們的產品推動醫療保健更加以患者為中心和基於價值。”

About Healixa, Inc.

Healixa公司簡介

Healixa is a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water generation and green-tech industries. Healixa embraces innovation by combining its intellectual properties, patents, strategic collaborations, and partnerships to create a "LaunchPad" of disruptive sustainable products.

Healixa是一家科技公司,專注於在健康科技、清潔水發電和綠色科技行業建立和收購創新和顛覆性技術。Healixa擁抱創新,將其知識產權、專利、戰略合作和合作夥伴關係結合在一起,創建了一個顛覆性可持續產品的“發射臺”。

Forward-looking Statements

前瞻性陳述

Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected research and development programs, and more. These forward-looking statements are based only on current expectations of management and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including but not limited to the risks and uncertainties related to the progress, timing, cost, and results of Partnerships and product development programs; difficulties or delays in obtaining regulatory approval or patent protection; and competition from other companies. Except as otherwise required by law, Healixa, Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

本新聞稿中包含的某些陳述可能構成前瞻性陳述。例如,在討論我們預期的研發計劃等時,會使用前瞻性陳述。這些前瞻性陳述僅基於對管理層的當前預期,受重大風險和不確定因素的影響,這些風險和不確定因素可能導致實際結果與前瞻性陳述中描述的大不相同,包括但不限於與合作伙伴關係和產品開發計劃的進度、時間、成本和結果有關的風險和不確定因素;在獲得監管批准或專利保護方面的困難或延遲;以及來自其他公司的競爭。除非法律另有要求,Healixa,Inc.沒有義務公開發布對這些前瞻性陳述的任何修訂,以反映本前瞻性陳述之後的事件或情況,或反映意外事件的發生。

Healixa, Inc. Contact

Healixa,Inc.聯繫人

Bret Hedges
SVP of Strategic Partnerships
833-432-5492
Bret@healixa.com

Bret Hedge
戰略合作伙伴關係高級副總裁
833-432-5492
郵箱:bret@healixa.com

Dave Gentry
RedChip Companies, Inc.
Phone: (407) 491-4498
EMOR@redchip.com

戴夫·金特里
紅籌公司。
電話:(407)491-4498
郵箱:Emor@redchip.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論